Low Dose Radioguided Parathyroidectomy for Hyperparathyroidism
Author Information
Author(s): Rubello Domenico, Al-Nahhas Adil, Mariani Giuliano, Gross Milton D, Rampin Lucia, Pelizzo Maria Rosa
Primary Institution: Nuclear Medicine Service, 'S. Maria della Misericordia' Hospital, Istituto Oncologico Veneto (IOV), Rovigo, Italy
Hypothesis
Is focused radioguided parathyroidectomy using a low dose of 99mTc-sestamibi feasible and effective compared to a high dose protocol?
Conclusion
Focused low dose radioguided parathyroidectomy is a safe and effective method for localizing parathyroid adenomas in patients with primary hyperparathyroidism.
Supporting Evidence
- Focused minimally invasive parathyroidectomy was successfully performed in 301 out of 320 patients.
- No major intraoperative complications were recorded.
- Mean operating time was 32 minutes with a mean hospital stay of 1.2 days.
- Local anesthesia was used in 75 patients, mostly older than 65 years.
- No cases of persistent or recurrent hyperparathyroidism were observed during follow-up.
Takeaway
Doctors can use a small amount of a special medicine to find and remove bad glands in the neck without making big cuts, which helps patients heal faster.
Methodology
The study involved 320 patients with primary hyperparathyroidism who underwent focused minimally invasive parathyroidectomy using a low dose of 99mTc-sestamibi.
Potential Biases
Potential bias due to the single-surgeon experience and selection criteria for surgery.
Limitations
The study may not be generalizable to all patients with primary hyperparathyroidism, especially those with multiple gland disease.
Participant Demographics
207 females and 113 males, mean age 55.3 years (range 16–83 years).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website